For this reason, GM-CSF is inserted into T-VEC, OH2, etc., to further enhance the ability of oncolytic virus to induce immunity against tumor, which has shown their great benefits in clinical trials [15,58]. This evidence concerns the gene CSF2 and neoplasm.